The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes
Open accessAbstract
Our study aimed to investigate the short-term efficacy and long-term prognosis of liver failure patients caused by hepatitis B after a single transplantation with autologous marrow mesenchymal stem cells (MMSCs). A total of 527 inpatients with liver failure caused by hepatitis B were recruited and received the same medical treatments, among whom 53 patients underwent a single transplantation with autologous MMSCs. A total of 105 patients matched for age, sex, and biochemical indexes, including alanine aminotransferase (ALT), albumin, total bilirubin (TBIL), prothrombin time (PT), and Model for End-Stage Liver Disease (MELD), comprised the control group. A total of 120 mL of bone marrow was obtained from each patient and then diluted and separated. Then, the MMSC suspension was slowly transfused into the liver through the proper hepatic artery. The success rate of transplantation was 100%, without serious side effects or complications. Levels of ALB, TBIL, and PT and MELD score of patients in the transplantation group were markedly improved from 2-3 weeks after transplantation, compared with those in the control group. At 192 weeks of follow-up, there were no dramatic differences in incidence of hepatocellular carcinoma (HCC) or mortality between the two groups. Additionally, there were no significant differences in the incidence of HCC or mortality between patients with and without cirrhosis in the transplantation group. Conclusion: Autologous MMSC transplantation is safe for liver failure patients caused by chronic hepatitis B. Short-term efficacy was favorable, but long-term outcomes were not markedly improved. In respect to several parameters, this method is preferable for patients with liver cirrhosis and may have potential for reducing their incidence of HCC and mortality. (HEPATOLOGY 2011;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedRisk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone Marrow
Mezey, E., Chandross, K. J., Harta, G., Maki, R. A., & McKercher, S. R. (2000) · Science · doi:10.1126/science.290.5497.1779 · Cited by 1,822
From Marrow to Brain: Expression of Neuronal Phenotypes in Adult Mice
Brazelton, T. R., Rossi, F. M. V., Keshet, G. I., & Blau, H. M. (2000) · Science · doi:10.1126/science.290.5497.1775 · Cited by 1,676
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., de Silva, H. J., Hamid, S. S., Jalan, R., Komolmit, P., et al. (2009) · Hepatology International · doi:10.1007/s12072-008-9106-x · Cited by 763
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492
Terai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., Yokoyama, Y., Uchida, K., Yamasaki, T., Fujii, Y., et al. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0542 · Cited by 491
Cited by
Mesenchymal stem cells: a new trend for cell therapy
Wei, X., Yang, X., Han, Z.-P., Qu, F.-F., Shao, L., & Shi, Y.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.50 · Cited by 942
Ethical and Safety Issues of Stem Cell-Based Therapy
Volarevic, V., Markovic, B. S., Gazdic, M., Volarevic, A., Jovicic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.21666 · Cited by 876
Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review
Berebichez-Fridman, R., & Montero-Olvera, P. R. (2018) · Sultan Qaboos University Medical Journal · doi:10.18295/squmj.2018.18.03.002 · Cited by 450
Shi, M., Zhang, Z., Xu, R., Lin, H., Fu, J., Zou, Z., Zhang, A., Shi, J., Chen, L., Lv, S., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0034 · Cited by 374
Suk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0019 · Cited by 307
Lin, B., Chen, J., Qiu, W., Wang, K., Xie, D., Chen, X., Liu, Q., Peng, L., Li, J., Mei, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29189 · Cited by 288
Self-citationMesenchymal stem cell therapy for liver fibrosis
Eom, Y. W., Shim, K. Y., & Baik, S. K. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.580 · Cited by 226
Mohamadnejad, M., Alimoghaddam, K., Bagheri, M., Ashrafi, M., Abdollahzadeh, L., Akhlaghpoor, S., Bashtar, M., Ghavamzadeh, A., & Malekzadeh, R. (2013) · Liver International · doi:10.1111/liv.12228 · Cited by 182
Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0105 · Cited by 155
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
Cell therapy for advanced liver diseases: repair or rebuild
Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.014 · Cited by 141
Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10199-2 · Cited by 151
Spahr, L., Chalandon, Y., Terraz, S., Kindler, V., Rubbia-Brandt, L., Frossard, J.-L., Breguet, R., Lanthier, N., Farina, A., Passweg, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053719 · Cited by 118
Li, J., Zhang, L., Xin, J., Jiang, L., Zhang, T., Jin, L., Li, J., Zhou, P., Hao, S., Cao, H., et al. (2012) · Hepatology · doi:10.1002/hep.25722 · Cited by 116
Yu, J., Yin, S., Zhang, W., Gao, F., Liu, Y., Chen, Z., Zhang, M., He, J., & Zheng, S. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt234 · Cited by 110
Liang, J., Zhang, H., Zhao, C., Wang, D., Ma, X., Zhao, S., Wang, S., Niu, L., & Sun, L. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13015 · Cited by 93
Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
Yuan, M., Hu, X., Yao, L., Jiang, Y., & Li, L. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02858-4 · Cited by 89
Review article: the reversibility of cirrhosis
Sohrabpour, A. A., Mohamadnejad, M., & Malekzadeh, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12044 · Cited by 80
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Kang, S. H., Kim, M. Y., Eom, Y. W., & Baik, S. K. (2020) · Gut and Liver · doi:10.5009/gnl18412 · Cited by 78
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71
Wang, P.-P., Xie, D.-Y., Liang, X.-J., Peng, L., Zhang, G.-L., Ye, Y.-N., Xie, C., & Gao, Z.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043408 · Cited by 55
Self-citationWang, K., Li, Y., Zhu, T., Zhang, Y., Li, W., Lin, W., Li, J., & Zhu, C. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0614-2 · Cited by 54
Mohamadnejad, M., Vosough, M., Moossavi, S., Nikfam, S., Mardpour, S., Akhlaghpoor, S., Ashrafi, M., Azimian, V., Jarughi, N., Hosseini, S.-E., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0004 · Cited by 53
Fang, X., Liu, L., Dong, J., Zhang, J., Song, H., Song, Y., Huang, Y., Cui, X., Lin, J., Chen, C., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14081 · Cited by 53
Lu, W., Qu, J., Yan, L., Tang, X., Wang, X., Ye, A., Zou, Z., Li, L., Ye, J., & Zhou, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03518-x · Cited by 49
Kojima, Y., Tsuchiya, A., Ogawa, M., Nojiri, S., Takeuchi, S., Watanabe, T., Nakajima, K., Hara, Y., Yamashita, J., Kikuta, J., et al. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.08.005 · Cited by 43
D'Avola, D., Fernández-Ruiz, V., Carmona-Torre, F., Méndez, M., Pérez-Calvo, J., Prósper, F., Andreu, E., Herrero, J. I., Iñarrairaegui, M., Fuertes, C., et al. (2017) · Translational Research · doi:10.1016/j.trsl.2016.02.009 · Cited by 34
Ma, X.-R., Tang, Y.-L., Xuan, M., Chang, Z., Wang, X.-Y., & Liang, X.-H. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/908275 · Cited by 34
Khalil, M. R., El-Demerdash, R. S., Elminshawy, H. H., Mehanna, E. T., Mesbah, N. M., & Abo-Elmatty, D. M. (2021) · Biomedical Journal · doi:10.1016/j.bj.2020.04.011 · Cited by 29
Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Huang, W.-C., Li, Y.-C., Chen, P.-X., Ma, K. S.-K., & Wang, L.-T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04127-y · Cited by 29
Current understanding of mesenchymal stem cells in liver diseases
Wu, M.-C., & Meng, Q.-H. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1349 · Cited by 29
Wang, H., Yao, W., Wang, Y., Dong, H., Dong, T., Zhou, W., Cui, L., Zhao, L., Zhang, Y., Shi, L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03494-2 · Cited by 28
Amadeo, F., Trivino Cepeda, K., Littlewood, J., Wilm, B., Taylor, A., & Murray, P. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210013 · Cited by 20
Nguyen, T. L., Nguyen, H. P., Ngo, D. M., Ha, T. H. T., Mai, K. A., Bui, T. H., Nguyen, P. V., Pham, L. H., Hoang, D. M., & Cao, A. D. T. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02762-x · Cited by 19
(2019) · Europe PMC (PubMed Central) · doi:10.22074/cellj.2019.6108 · Cited by 18
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
Tao, Y.-C., & Chen, E.-Q. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.153 · Cited by 15
Chen, B., Pang, L., Cao, H., Wu, D., Wang, Y., Tao, Y., Wang, M., & Chen, E. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001455 · Cited by 14
Deng, Q., Cai, T., Zhang, S., Hu, A., Zhang, X., Wang, Y., & Huang, J. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.32498 · Cited by 11
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
Metadata
- Authors
- Peng, L., Xie, D.-Y., Lin, B.-L., Liu, J., Zhu, H.-P., Xie, C., Zheng, Y.-B., & Gao, Z.-L.
- Venue
- Hepatology
- Published
- 2011-09-02
- Volume
- 54
- Issue
- 3
- Pages
- 820-828
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2105336157
- Cited by
- 365
- References
- 27
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.